Arcxis Lands $1M Homeland Security Award for DNA-Based Anthrax, Plague Dx | GenomeWeb
NEW YORK (GenomeWeb News) — Arcxis Biotechnologies has received a $1 million Phase II award from the US Department of Homeland Security to continue developing its BioPhalanx instrument, a portable, rapid-detection bio-threat analyzer, the company said Tuesday. 
The Pleasanton, Calif.-based company said the funding comes after it demonstrated a genomic probe assay for viruses causing anthrax and plague that does not report false positive results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.